Latest filing published 24 May 2021 for CV Sciences, Inc., €16k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Joseph C. Maroon MD span 3 companies, the busiest being Mylan Laboratories Inc, Mylan II B.V. and CV Sciences, Inc. In total, 43 filings cover trades dated from 2 August 2007 to 21 May 2021.
On the open market, the record shows 12 purchases worth €499k and 5 sales worth €7.7M. Sales outweigh purchases by €7.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 23 option exercises. In 2021 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €19k and half below. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 24 May 2021 with an open-market purchase (€16k) in CV Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations